GLYCOPYRROLATE AND FORMOTEROL FUMARATE

GLYCOPYRROLATE AND FORMOTEROL FUMARATE was reported 1968 times

GLYCOPYRROLATE AND FORMOTEROL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LEUKAEMIA BASOPHILIC 1 0.3333
1 MESENTERIC THICKENING 1 0.2000
2 FREE ANDROGEN INDEX DECREASED 1 0.1429
3 PERIPHERAL ARTERY RESTENOSIS 1 0.1000
4 GIARDIA TEST POSITIVE 1 0.0909
5 TENODESIS 2 0.0606
6 BLOOD CARBON MONOXIDE ABNORMAL 1 0.0556
7 IMPACTED FRACTURE 1 0.0417
8 APOLIPOPROTEIN B INCREASED 1 0.0270
9 DEVICE EFFECT DECREASED 1 0.0256
10 DECREASED BRONCHIAL SECRETION 1 0.0256
11 INTENTIONAL DEVICE MISUSE 106 0.0240
12 CAUTERY TO NOSE 1 0.0192
13 OPHTHALMIC ARTERY OCCLUSION 1 0.0172
14 BRONCHOALVEOLAR LAVAGE 1 0.0164
15 MYRINGITIS 1 0.0135
16 ALCOHOLIC SEIZURE 1 0.0135
17 HEART ALTERNATION 1 0.0125
18 ADRENAL SUPPRESSION 9 0.0107
19 LUNG DIFFUSION TEST ABNORMAL 1 0.0103
20 CATARRH 9 0.0100
21 DRUG DELIVERY SYSTEM ISSUE 18 0.0091
22 PERIPHERAL NERVE DECOMPRESSION 1 0.0081
23 BLOOD TESTOSTERONE FREE DECREASED 1 0.0076
24 COUGH DECREASED 1 0.0075
25 DEVICE INEFFECTIVE 8 0.0075
26 OROPHARYNGEAL ERYTHEMA 1 0.0068
27 OFF LABEL USE OF DEVICE 9 0.0067
28 BRONCHOSPASM PARADOXICAL 2 0.0066
29 IMPAIRED FASTING GLUCOSE 2 0.0066
30 NONINFECTIVE SIALOADENITIS 1 0.0063
31 BLOOD FOLATE INCREASED 1 0.0060
32 DOSING ERROR 1 0.0060
33 BLOOD ZINC DECREASED 1 0.0055
34 MALIGNANT POLYP 1 0.0053
35 BRONCHIAL IRRITATION 1 0.0052
36 EXPOSURE TO UNSPECIFIED AGENT 1 0.0051
37 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
38 GRANULOCYTES ABNORMAL 1 0.0050
39 OROPHARYNGITIS FUNGAL 1 0.0050
40 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
41 DEVICE USE ISSUE 82 0.0047
42 INTENTIONAL DEVICE USE ISSUE 4 0.0047
43 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
44 LARYNX IRRITATION 1 0.0043
45 BRONCHOSCOPY 1 0.0042
46 ILLNESS ANXIETY DISORDER 1 0.0041
47 PARANASAL SINUS HYPOSECRETION 1 0.0040
48 CYANOSIS CENTRAL 1 0.0038
49 DEVICE USE CONFUSION 2 0.0038
50 KYPHOSCOLIOSIS 1 0.0038
51 BODY TEMPERATURE 1 0.0037
52 INFUSION SITE THROMBOSIS 1 0.0037
53 LIMB TRAUMATIC AMPUTATION 1 0.0037
54 COLON CANCER RECURRENT 1 0.0036
55 CARDIO-RESPIRATORY DISTRESS 1 0.0035
56 DEVICE DELIVERY SYSTEM ISSUE 95 0.0035
57 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
58 GASTROINTESTINAL MUCOSA HYPERAEMIA 1 0.0034
59 IDIOPATHIC PNEUMONIA SYNDROME 1 0.0034
60 OXYGEN CONSUMPTION DECREASED 2 0.0033
61 BODY HEIGHT DECREASED 35 0.0033
62 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 2 0.0033
63 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 150 0.0032
64 INCREASED DOSE ADMINISTERED 1 0.0032
65 NODAL OSTEOARTHRITIS 1 0.0031
66 INJECTION SITE THROMBOSIS 1 0.0030
67 PERIPHERAL NERVE LESION 1 0.0030
68 ABDOMINOPLASTY 1 0.0030
69 PERIVASCULAR DERMATITIS 1 0.0030
70 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 156 0.0030
71 LUNG PERFORATION 1 0.0030
72 DETOXIFICATION 1 0.0029
73 DIAPHRAGMALGIA 1 0.0029
74 EYE SYMPTOM 1 0.0028
75 DEVICE FAILURE 42 0.0028
76 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 2 0.0026
77 DRUG DELIVERY SYSTEM MALFUNCTION 13 0.0025
78 AMMONIA ABNORMAL 1 0.0025
79 INCORRECT DOSE ADMINISTERED BY DEVICE 65 0.0025
80 GRANULOCYTE COUNT INCREASED 1 0.0025
81 CLUBBING 1 0.0025
82 OESOPHAGEAL RUPTURE 2 0.0024
83 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
84 NAIL BED DISORDER 1 0.0023
85 COLONOSCOPY ABNORMAL 1 0.0023
86 HEARING AID USER 1 0.0023
87 HEART VALVE OPERATION 1 0.0023
88 DEVICE MALFUNCTION 161 0.0023
89 PANCREATIC ATROPHY 1 0.0023
90 INFUSION SITE SCAR 1 0.0023
91 BLOOD IRON ABNORMAL 2 0.0020
92 EMPHYSEMA 20 0.0020
93 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
94 CAPILLARY FRAGILITY 1 0.0020
95 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
96 COATING IN MOUTH 1 0.0019
97 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
98 MILK ALLERGY 1 0.0018
99 BRAIN SCAN ABNORMAL 1 0.0018
100 HALO VISION 2 0.0018
101 COLON INJURY 1 0.0017
102 DYSLEXIA 2 0.0017
103 PLATELET COUNT 1 0.0017
104 DEVICE ISSUE 145 0.0016
105 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
106 LIP DISCOLOURATION 2 0.0016
107 BRONCHIAL SECRETION RETENTION 2 0.0016
108 ANAL INFLAMMATION 1 0.0016
109 URINARY TRACT DISORDER 7 0.0016
110 JOB DISSATISFACTION 1 0.0015
111 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
112 GINGIVAL DISCOMFORT 1 0.0015
113 ORAL MUCOSAL DISCOLOURATION 1 0.0015
114 INFUSION SITE URTICARIA 1 0.0015
115 CANDIDA INFECTION 25 0.0015
116 PNEUMOTHORAX SPONTANEOUS 1 0.0015
117 ANGULAR CHEILITIS 1 0.0014
118 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
119 NONINFECTIVE ENCEPHALITIS 1 0.0014
120 SPUTUM INCREASED 3 0.0014
121 PRODUCT LOT NUMBER ISSUE 3 0.0014
122 PARATHYROID TUMOUR BENIGN 1 0.0013
123 INTENTIONAL PRODUCT MISUSE 118 0.0013
124 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
125 MULTIPLE DRUG THERAPY 1 0.0013
126 DEVICE DEFECTIVE 23 0.0013
127 DIZZINESS EXERTIONAL 1 0.0013
128 RESPIRATION ABNORMAL 9 0.0013
129 ORAL MUCOSAL ERUPTION 2 0.0013
130 BRONCHIAL CARCINOMA 1 0.0013
131 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 3 0.0013
132 URINE FLOW DECREASED 3 0.0013
133 DEVICE DAMAGE 1 0.0013
134 TOTAL LUNG CAPACITY DECREASED 2 0.0013
135 BRONCHITIS CHRONIC 3 0.0012
136 FEAR OF FALLING 1 0.0012
137 OXYGEN THERAPY 2 0.0012
138 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
139 MYCOTIC ALLERGY 1 0.0012
140 LUNG HYPERINFLATION 1 0.0012
141 PULMONARY FUNCTION TEST DECREASED 5 0.0011
142 INFUSION SITE DISCHARGE 2 0.0011
143 PRODUCT CLEANING INADEQUATE 3 0.0011
144 PRODUCT DOSE OMISSION 73 0.0011
145 SECRETION DISCHARGE 14 0.0011
146 ARTERIOVENOUS MALFORMATION 1 0.0011
147 ANEURYSM RUPTURED 1 0.0011
148 PHARYNGEAL HYPOAESTHESIA 1 0.0011
149 BONE GRAFT 1 0.0011
150 STENOSIS 2 0.0011
151 PRODUCT AFTER TASTE 1 0.0010
152 INSURANCE ISSUE 16 0.0010
153 CORRECTIVE LENS USER 1 0.0010
154 INABILITY TO AFFORD MEDICATION 10 0.0010
155 INTRACRANIAL ANEURYSM 4 0.0010
156 IMMUNE-MEDIATED DERMATITIS 1 0.0010
157 ILEAL ULCER 1 0.0010
158 PRODUCT DELIVERY MECHANISM ISSUE 5 0.0009
159 ABSCESS INTESTINAL 2 0.0009
160 INFUSION SITE MASS 1 0.0009
161 HAEMORRHAGIC DISORDER 1 0.0009
162 EXPIRED DEVICE USED 3 0.0009
163 ESSENTIAL TREMOR 1 0.0009
164 MULTIPLE ALLERGIES 7 0.0009
165 FEELING JITTERY 17 0.0009
166 DRY THROAT 9 0.0009
167 DISEASE COMPLICATION 4 0.0009
168 MICTURITION DISORDER 3 0.0009
169 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 29 0.0009
170 INCISION SITE PAIN 1 0.0009
171 PNEUMONIA INFLUENZAL 1 0.0008
172 OXYGEN CONSUMPTION INCREASED 2 0.0008
173 GLAUCOMA 16 0.0008
174 PULSE ABNORMAL 2 0.0008
175 PHARYNGEAL INFLAMMATION 1 0.0008
176 LARGE INTESTINE INFECTION 1 0.0008
177 HAEMATOCRIT ABNORMAL 1 0.0008
178 DYSPHONIA 47 0.0008
179 BLADDER DISCOMFORT 1 0.0008
180 HYPERPARATHYROIDISM SECONDARY 2 0.0008
181 AORTIC VALVE REPLACEMENT 1 0.0008
182 GASTRIC ULCER PERFORATION 1 0.0008
183 FRACTURED COCCYX 1 0.0008
184 LIP HAEMORRHAGE 1 0.0008
185 PRODUCTIVE COUGH 37 0.0008
186 PROSTATOMEGALY 3 0.0008
187 OESOPHAGEAL HAEMORRHAGE 1 0.0008
188 GASTROENTERITIS NOROVIRUS 1 0.0008
189 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
190 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
191 OVERWEIGHT 4 0.0007
192 ADRENAL INSUFFICIENCY 9 0.0007
193 ABDOMINAL RIGIDITY 2 0.0007
194 CARBON DIOXIDE INCREASED 1 0.0007
195 INTESTINAL MASS 1 0.0007
196 CHOKING SENSATION 4 0.0007
197 PROSTATIC DISORDER 4 0.0007
198 PHARYNGEAL SWELLING 7 0.0007
199 INTESTINAL FISTULA 1 0.0007
200 TONGUE DISCOMFORT 3 0.0007
201 APPENDIX DISORDER 1 0.0007
202 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
203 AUDITORY DISORDER 1 0.0007
204 OXYGEN SATURATION ABNORMAL 2 0.0007
205 CHAPPED LIPS 3 0.0007
206 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
207 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
208 PULMONARY PAIN 2 0.0007
209 GENERALISED ANXIETY DISORDER 1 0.0007
210 WHEELCHAIR USER 3 0.0007
211 KNEE DEFORMITY 1 0.0007
212 GASTROINTESTINAL WALL THICKENING 1 0.0007
213 DYSPNOEA 378 0.0007
214 HYPOSMIA 1 0.0007
215 URINARY RETENTION 22 0.0007
216 WHEEZING 39 0.0007
217 GASTRITIS EROSIVE 3 0.0006
218 BLOOD BLISTER 2 0.0006
219 SEASONAL ALLERGY 9 0.0006
220 INFUSION SITE PRURITUS 2 0.0006
221 INTERMITTENT CLAUDICATION 1 0.0006
222 OVARIAN CANCER RECURRENT 1 0.0006
223 COLON CANCER METASTATIC 1 0.0006
224 RASH VESICULAR 3 0.0006
225 FRUSTRATION TOLERANCE DECREASED 5 0.0006
226 DYSGRAPHIA 4 0.0006
227 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
228 ARTHROPOD STING 1 0.0006
229 MEDICAL PROCEDURE 1 0.0006
230 EROSIVE OESOPHAGITIS 1 0.0006
231 FOOD AVERSION 1 0.0006
232 VITAMIN D DECREASED 5 0.0006
233 COUGH 164 0.0006
234 DYSPNOEA EXERTIONAL 22 0.0006
235 DYSURIA 21 0.0006
236 KYPHOSIS 1 0.0006
237 PANCREATIC FAILURE 1 0.0006
238 GLOSSITIS 2 0.0006
239 AORTIC VALVE STENOSIS 1 0.0006
240 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
241 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 113 0.0006
242 APPARENT DEATH 2 0.0006
243 OBSESSIVE THOUGHTS 1 0.0006
244 OROPHARYNGEAL DISCOMFORT 5 0.0006
245 CHEST DISCOMFORT 56 0.0005
246 OPPORTUNISTIC INFECTION 1 0.0005
247 THROAT IRRITATION 24 0.0005
248 ORAL CANDIDIASIS 7 0.0005
249 SNORING 2 0.0005
250 SPUTUM DISCOLOURED 5 0.0005
251 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
252 PRODUCT LABEL CONFUSION 3 0.0005
253 LUNG DISORDER 25 0.0005
254 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
255 MACULAR DEGENERATION 6 0.0005
256 OESOPHAGEAL CANDIDIASIS 2 0.0005
257 APHONIA 7 0.0005
258 OXYGEN SATURATION DECREASED 28 0.0005
259 FUNGAL SKIN INFECTION 2 0.0005
260 EAR HAEMORRHAGE 1 0.0005
261 SPINAL STENOSIS 2 0.0005
262 SENSATION OF FOREIGN BODY 4 0.0005
263 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
264 PULMONARY MASS 7 0.0005
265 PRODUCT DOSE OMISSION ISSUE 138 0.0005
266 PRODUCT USE ISSUE 88 0.0005
267 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
268 DECREASED ACTIVITY 5 0.0005
269 MUSCLE STRAIN 4 0.0005
270 ONYCHOMYCOSIS 2 0.0005
271 PULMONARY CONGESTION 6 0.0005
272 BRONCHIECTASIS 3 0.0004
273 PRODUCT LABEL ISSUE 3 0.0004
274 PNEUMOTHORAX 7 0.0004
275 LUNG NEOPLASM MALIGNANT 18 0.0004
276 ORAL PRURITUS 1 0.0004
277 HAIR GROWTH ABNORMAL 3 0.0004
278 SYNOVIAL CYST 2 0.0004
279 NEPHROGENIC ANAEMIA 2 0.0004
280 PRODUCT DISTRIBUTION ISSUE 4 0.0004
281 NECK SURGERY 1 0.0004
282 ESCHERICHIA BACTERAEMIA 1 0.0004
283 DUODENAL ULCER 3 0.0004
284 PANCREATITIS CHRONIC 1 0.0004
285 NERVOUSNESS 22 0.0004
286 GASTROINTESTINAL OBSTRUCTION 1 0.0004
287 PAINFUL RESPIRATION 1 0.0004
288 NOCTURIA 5 0.0004
289 INCORRECT DOSAGE ADMINISTERED 2 0.0004
290 HAEMATOLOGICAL INFECTION 1 0.0004
291 DRUG DOSE OMISSION BY DEVICE 32 0.0004
292 SENSITIVE SKIN 3 0.0004
293 BREATH SOUNDS ABNORMAL 2 0.0004
294 HYPERVOLAEMIA 2 0.0004
295 DEVICE INFUSION ISSUE 1 0.0004
296 POOR QUALITY DEVICE USED 4 0.0004
297 LABYRINTHITIS 1 0.0004
298 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
299 MEAN CELL VOLUME INCREASED 1 0.0004
300 THYROID DISORDER 6 0.0004
301 PERIPHERAL VASCULAR DISORDER 2 0.0004
302 WEIGHT FLUCTUATION 4 0.0004
303 PERSONALITY DISORDER 1 0.0004
304 PRODUCT USE COMPLAINT 6 0.0004
305 VISUAL IMPAIRMENT 47 0.0004
306 SCRATCH 4 0.0004
307 ANIMAL BITE 1 0.0004
308 BLOOD POTASSIUM ABNORMAL 1 0.0004
309 ALCOHOL POISONING 1 0.0004
310 PRODUCT TASTE ABNORMAL 5 0.0004
311 EAR CONGESTION 1 0.0004
312 LIP BLISTER 1 0.0004
313 TIC 2 0.0004
314 POLYURIA 3 0.0004
315 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
316 CYSTIC FIBROSIS 2 0.0004
317 EOSINOPHIL COUNT INCREASED 3 0.0004
318 ORAL DISCOMFORT 5 0.0004
319 DIABETIC COMA 1 0.0004
320 PROCTITIS 1 0.0004
321 PANCREATIC CARCINOMA METASTATIC 1 0.0004
322 LIP PAIN 1 0.0003
323 IMPAIRED QUALITY OF LIFE 5 0.0003
324 EXERCISE TOLERANCE DECREASED 2 0.0003
325 HYPERTONIC BLADDER 1 0.0003
326 EYELID MARGIN CRUSTING 1 0.0003
327 HYPERVENTILATION 2 0.0003
328 RALES 2 0.0003
329 HIP FRACTURE 11 0.0003
330 PRODUCT PRESCRIBING ERROR 8 0.0003
331 POLLAKIURIA 14 0.0003
332 MEMORY IMPAIRMENT 46 0.0003
333 BRAIN HERNIATION 1 0.0003
334 INFUSION SITE REACTION 1 0.0003
335 ATYPICAL PNEUMONIA 1 0.0003
336 EMERGENCY CARE 1 0.0003
337 MENISCUS INJURY 2 0.0003
338 IRON DEFICIENCY ANAEMIA 3 0.0003
339 BRONCHITIS 24 0.0003
340 PRE-EXISTING CONDITION IMPROVED 2 0.0003
341 ASTHMA 36 0.0003
342 PANCREATIC CARCINOMA STAGE IV 1 0.0003
343 POLYMYALGIA RHEUMATICA 1 0.0003
344 RESPIRATORY TRACT CONGESTION 5 0.0003
345 SLEEP APNOEA SYNDROME 6 0.0003
346 OROPHARYNGEAL PAIN 29 0.0003
347 INTRAOCULAR PRESSURE INCREASED 4 0.0003
348 HIATUS HERNIA 4 0.0003
349 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
350 BACK DISORDER 5 0.0003
351 VITREOUS FLOATERS 3 0.0003
352 THERAPY CHANGE 3 0.0003
353 INFUSION SITE HAEMORRHAGE 1 0.0003
354 HOSPICE CARE 3 0.0003
355 CATARACT 18 0.0003
356 APPETITE DISORDER 2 0.0003
357 ANXIETY DISORDER 1 0.0003
358 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
359 COLITIS ISCHAEMIC 2 0.0003
360 FEEDING DISORDER 6 0.0003
361 ABNORMAL LOSS OF WEIGHT 2 0.0003
362 DEVICE MECHANICAL ISSUE 4 0.0003
363 CORONARY ARTERY OCCLUSION 4 0.0003
364 LEFT VENTRICULAR FAILURE 1 0.0003
365 LARGE INTESTINE POLYP 2 0.0003
366 SWOLLEN TONGUE 9 0.0003
367 AORTIC STENOSIS 1 0.0003
368 CAROTID ARTERY STENOSIS 1 0.0003
369 DEMENTIA 8 0.0003
370 BRONCHIOLITIS 1 0.0003
371 PRODUCT USE IN UNAPPROVED INDICATION 70 0.0003
372 DIVERTICULUM 2 0.0003
373 FIBRIN D DIMER INCREASED 1 0.0003
374 HAEMORRHAGIC DIATHESIS 1 0.0003
375 APPENDICECTOMY 1 0.0003
376 PANIC REACTION 2 0.0003
377 NASAL CONGESTION 16 0.0003
378 COLON CANCER 4 0.0003
379 CHRONIC SINUSITIS 1 0.0003
380 AUTOIMMUNE THYROIDITIS 1 0.0003
381 RHINORRHOEA 17 0.0003
382 AORTIC ANEURYSM 2 0.0003
383 TROPONIN INCREASED 2 0.0003
384 BOWEL MOVEMENT IRREGULARITY 2 0.0003
385 OESOPHAGEAL DISORDER 1 0.0003
386 EAR PAIN 5 0.0003
387 PELVIC FRACTURE 2 0.0003
388 MUSCLE RUPTURE 1 0.0003
389 CHOKING 5 0.0003
390 ORAL INFECTION 1 0.0003
391 HYPOACUSIS 11 0.0003
392 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
393 GINGIVAL PAIN 2 0.0003
394 HYPERLIPIDAEMIA 3 0.0003
395 HAEMOPTYSIS 7 0.0003
396 OBSTRUCTION 1 0.0003
397 SPINAL FRACTURE 5 0.0002
398 BLEPHARITIS 1 0.0002
399 PERIPHERAL SWELLING 38 0.0002
400 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
401 PERIPHERAL ISCHAEMIA 1 0.0002
402 HYPERAESTHESIA 2 0.0002
403 HYPERURICAEMIA 1 0.0002
404 EYE DISORDER 8 0.0002
405 ANAPHYLACTOID REACTION 1 0.0002
406 FEELING ABNORMAL 58 0.0002
407 DEATH 207 0.0002
408 PULMONARY HYPERTENSION 5 0.0002
409 WEIGHT DECREASED 66 0.0002
410 BUNDLE BRANCH BLOCK LEFT 1 0.0002
411 AORTIC VALVE INCOMPETENCE 1 0.0002
412 EATING DISORDER 5 0.0002
413 POOR PERIPHERAL CIRCULATION 1 0.0002
414 INTERVERTEBRAL DISC DISORDER 1 0.0002
415 DRY MOUTH 19 0.0002
416 LUNG NEOPLASM 1 0.0002
417 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
418 DRUG DOSE OMISSION 38 0.0002
419 URINE OUTPUT DECREASED 2 0.0002
420 PNEUMONIA 74 0.0002
421 IMMUNOSUPPRESSION 2 0.0002
422 PRODUCT COMMUNICATION ISSUE 2 0.0002
423 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
424 BLOOD CREATINE INCREASED 1 0.0002
425 ATRIAL FIBRILLATION 22 0.0002
426 BRAIN NEOPLASM MALIGNANT 1 0.0002
427 ORAL PAIN 5 0.0002
428 MENINGITIS ASEPTIC 1 0.0002
429 IRON DEFICIENCY 1 0.0002
430 SINUS CONGESTION 3 0.0002
431 HEART RATE IRREGULAR 5 0.0002
432 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
433 RESTLESS LEGS SYNDROME 4 0.0002
434 PRODUCT AVAILABILITY ISSUE 5 0.0002
435 BONE DISORDER 4 0.0002
436 PNEUMONIA BACTERIAL 2 0.0002
437 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
438 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
439 RESPIRATORY DISTRESS 6 0.0002
440 EYE OPERATION 1 0.0002
441 NERVE COMPRESSION 2 0.0002
442 EYE SWELLING 8 0.0002
443 BLOOD CHOLESTEROL INCREASED 10 0.0002
444 FEELING OF DESPAIR 1 0.0002
445 THERAPY CESSATION 11 0.0002
446 MIDDLE INSOMNIA 4 0.0002
447 TACHYCARDIA 19 0.0002
448 PALPITATIONS 25 0.0002
449 HEART RATE INCREASED 21 0.0002
450 LEUKAEMIA 2 0.0002
451 SPINAL DISORDER 2 0.0002
452 VISUAL ACUITY REDUCED 7 0.0002
453 INTENTIONAL DOSE OMISSION 6 0.0002
454 BRONCHOSPASM 3 0.0002
455 LIP SWELLING 7 0.0002
456 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
457 NON-SMALL CELL LUNG CANCER 1 0.0002
458 PULMONARY FIBROSIS 4 0.0002
459 LOWER LIMB FRACTURE 4 0.0002
460 ACUTE RESPIRATORY FAILURE 4 0.0002
461 GUILLAIN-BARRE SYNDROME 1 0.0002
462 MENTAL IMPAIRMENT 5 0.0002
463 AUTOIMMUNE DISORDER 2 0.0002
464 URINARY TRACT INFECTION 35 0.0002
465 PANCREATIC DISORDER 1 0.0002
466 URINARY INCONTINENCE 6 0.0002
467 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
468 BLADDER DISORDER 2 0.0002
469 BONE LOSS 3 0.0002
470 BRAIN INJURY 2 0.0002
471 HYPOXIA 7 0.0002
472 OSTEOPOROSIS 8 0.0002
473 ANKLE FRACTURE 3 0.0002
474 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
475 RESPIRATORY TRACT INFECTION 5 0.0002
476 UNDERDOSE 14 0.0002
477 SPEECH DISORDER 10 0.0002
478 FOOD CRAVING 1 0.0002
479 OCULAR HYPERAEMIA 9 0.0002
480 ANORECTAL DISCOMFORT 1 0.0002
481 COMPRESSION FRACTURE 1 0.0002
482 CHRONIC KIDNEY DISEASE 14 0.0002
483 SKIN LACERATION 2 0.0002
484 BACK INJURY 2 0.0002
485 PULMONARY THROMBOSIS 2 0.0002
486 FAECALOMA 1 0.0002
487 ASTHENOPIA 1 0.0002
488 CARDIAC DISORDER 17 0.0002
489 HYPERKERATOSIS 1 0.0002
490 FUNGAL INFECTION 6 0.0002
491 MUSCLE SPASMS 33 0.0002
492 NEOPLASM MALIGNANT 12 0.0002
493 GAIT INABILITY 6 0.0002
494 INTRACRANIAL PRESSURE INCREASED 1 0.0002
495 HEART RATE ABNORMAL 1 0.0002
496 ANGIOPATHY 1 0.0002
497 TYPE 2 DIABETES MELLITUS 6 0.0002
498 PRODUCT LEAKAGE 1 0.0002
499 CHEST PAIN 33 0.0002
500 EYE INFECTION 2 0.0002
501 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
502 SCAB 2 0.0002
503 SCAR 3 0.0002
504 INTERNAL HAEMORRHAGE 2 0.0002
505 CARDIAC VALVE DISEASE 1 0.0002
506 VISION BLURRED 24 0.0002
507 ILLNESS 18 0.0002
508 MUSCULOSKELETAL DISCOMFORT 3 0.0002
509 OFF LABEL USE 152 0.0002
510 MOUTH SWELLING 1 0.0002
511 MYOCARDIAL INFARCTION 30 0.0002
512 INCORRECT DOSE ADMINISTERED 39 0.0002
513 BLOOD PRESSURE INCREASED 26 0.0002
514 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
515 SWELLING FACE 11 0.0002
516 BLOOD IRON DECREASED 2 0.0002
517 THIRST 3 0.0002
518 BURSITIS 2 0.0002
519 PANIC ATTACK 6 0.0002
520 INGUINAL HERNIA 1 0.0002
521 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
522 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
523 THINKING ABNORMAL 3 0.0002
524 AGEUSIA 4 0.0002
525 NASAL DRYNESS 1 0.0002
526 INFUSION SITE SWELLING 1 0.0002
527 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
528 FOOT FRACTURE 3 0.0002
529 PHOTOPSIA 1 0.0002
530 BLOOD URINE PRESENT 3 0.0002
531 PULMONARY OEDEMA 7 0.0002
532 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
533 ENTERITIS 1 0.0002
534 ROTATOR CUFF SYNDROME 2 0.0002
535 HAEMOGLOBIN ABNORMAL 1 0.0002
536 INFUSION SITE PAIN 2 0.0002
537 CARDIAC FLUTTER 1 0.0002
538 ASPERGILLUS INFECTION 1 0.0002
539 DISABILITY 3 0.0002
540 SINUS DISORDER 3 0.0002
541 CORONAVIRUS INFECTION 1 0.0002
542 UPPER LIMB FRACTURE 3 0.0002
543 CARDIAC FAILURE ACUTE 1 0.0001
544 QUALITY OF LIFE DECREASED 2 0.0001
545 ANGER 5 0.0001
546 OEDEMA 8 0.0001
547 BLINDNESS 6 0.0001
548 BLOOD TESTOSTERONE DECREASED 1 0.0001
549 JOINT EFFUSION 1 0.0001
550 PROCEDURAL PAIN 4 0.0001
551 LARGE INTESTINE PERFORATION 1 0.0001
552 FORMICATION 1 0.0001
553 EXTRASYSTOLES 1 0.0001
554 MASS 2 0.0001
555 CARPAL TUNNEL SYNDROME 2 0.0001
556 COVID-19 25 0.0001
557 DEVICE OCCLUSION 2 0.0001
558 BACK PAIN 33 0.0001
559 HYPERTENSION 30 0.0001
560 HAND FRACTURE 1 0.0001
561 GAIT DISTURBANCE 27 0.0001
562 DRY EYE 7 0.0001
563 ANGINA PECTORIS 4 0.0001
564 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
565 SKIN CANCER 3 0.0001
566 HYPERTHYROIDISM 2 0.0001
567 PRODUCT DISPENSING ERROR 3 0.0001
568 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
569 APATHY 2 0.0001
570 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
571 ORAL DISORDER 1 0.0001
572 MOUTH HAEMORRHAGE 1 0.0001
573 BLINDNESS TRANSIENT 1 0.0001
574 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
575 HYPOPHOSPHATAEMIA 1 0.0001
576 CEREBRAL DISORDER 1 0.0001
577 SKIN HAEMORRHAGE 2 0.0001
578 FEELING DRUNK 1 0.0001
579 ABDOMINAL DISTENSION 14 0.0001
580 DECREASED APPETITE 31 0.0001
581 BLOOD POTASSIUM DECREASED 4 0.0001
582 CHROMATURIA 3 0.0001
583 LACRIMATION INCREASED 4 0.0001
584 STOMATITIS 8 0.0001
585 HEPATOCELLULAR CARCINOMA 1 0.0001
586 MUSCLE TWITCHING 3 0.0001
587 CEREBROVASCULAR ACCIDENT 22 0.0001
588 ATRIOVENTRICULAR BLOCK 1 0.0001
589 MUSCULOSKELETAL CHEST PAIN 2 0.0001
590 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
591 APHTHOUS ULCER 1 0.0001
592 THERAPY PARTIAL RESPONDER 2 0.0001
593 BASAL CELL CARCINOMA 2 0.0001
594 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
595 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
596 SINUSITIS 13 0.0001
597 ANAPHYLACTIC REACTION 7 0.0001
598 TREMOR 21 0.0001
599 NASAL DISCOMFORT 1 0.0001
600 ABSCESS 2 0.0001
601 ATRIAL FLUTTER 1 0.0001
602 PRODUCT QUALITY ISSUE 17 0.0001
603 WEIGHT INCREASED 28 0.0001
604 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
605 BLOOD DISORDER 1 0.0001
606 SENSORY DISTURBANCE 2 0.0001
607 CARDIAC FAILURE 10 0.0001
608 CARDIAC FAILURE CONGESTIVE 10 0.0001
609 FIBROMYALGIA 3 0.0001
610 NEURALGIA 3 0.0001
611 POST PROCEDURAL INFECTION 1 0.0001
612 AMNESIA 8 0.0001
613 ABNORMAL FAECES 1 0.0001
614 EXPIRED PRODUCT ADMINISTERED 4 0.0001
615 HEMIPLEGIA 1 0.0001
616 INSOMNIA 32 0.0001
617 EYE PRURITUS 4 0.0001
618 INFUSION SITE ERYTHEMA 1 0.0001
619 FLUID RETENTION 6 0.0001
620 HYPOPHAGIA 3 0.0001
621 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
622 PRODUCT CONTAINER ISSUE 1 0.0001
623 INFLUENZA 13 0.0001
624 GASTRIC DISORDER 4 0.0001
625 DIPLOPIA 3 0.0001
626 PLEURAL EFFUSION 7 0.0001
627 NAIL DISORDER 1 0.0001
628 ANHEDONIA 3 0.0001
629 BLOOD CALCIUM INCREASED 1 0.0001
630 HEART RATE DECREASED 4 0.0001
631 LYMPHOCYTE COUNT DECREASED 2 0.0001
632 HYPERSENSITIVITY 21 0.0001
633 FACIAL PAIN 1 0.0001
634 GOUT 2 0.0001
635 GASTROENTERITIS VIRAL 2 0.0001
636 LIMB INJURY 3 0.0001
637 LIP DRY 1 0.0001
638 PELVIC PAIN 2 0.0001
639 END STAGE RENAL DISEASE 2 0.0001
640 EXOSTOSIS 1 0.0001
641 BRAIN NEOPLASM 1 0.0001
642 INCREASED TENDENCY TO BRUISE 1 0.0001
643 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
644 DIVERTICULITIS 3 0.0001
645 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
646 BREAST CANCER STAGE I 1 0.0001
647 JOINT SWELLING 13 0.0001
648 NECK PAIN 6 0.0001
649 RENAL DISORDER 5 0.0001
650 ERYTHEMA MULTIFORME 1 0.0001
651 SWELLING 10 0.0001
652 FLANK PAIN 1 0.0001
653 SKIN EXFOLIATION 9 0.0001
654 BLOOD SODIUM DECREASED 2 0.0001
655 PAIN IN JAW 3 0.0001
656 FLATULENCE 6 0.0001
657 RASH 46 0.0001
658 DYSPHAGIA 10 0.0001
659 CONFUSIONAL STATE 17 0.0001
660 MUSCULOSKELETAL DISORDER 2 0.0001
661 RED BLOOD CELL COUNT DECREASED 3 0.0001
662 POST PROCEDURAL COMPLICATION 2 0.0001
663 AFFECT LABILITY 1 0.0001
664 HYPERCHOLESTEROLAEMIA 1 0.0001
665 ATELECTASIS 1 0.0001
666 DIZZINESS POSTURAL 1 0.0001
667 DYSSTASIA 3 0.0001
668 HAEMORRHOIDS 2 0.0001
669 INFLAMMATORY BOWEL DISEASE 1 0.0001
670 COELIAC DISEASE 1 0.0001
671 KIDNEY INFECTION 2 0.0001
672 ALOPECIA 20 0.0001
673 HEPATOMEGALY 1 0.0001
674 ARTHRITIS 8 0.0001
675 BODY TEMPERATURE DECREASED 1 0.0001
676 BLOOD PRESSURE ABNORMAL 2 0.0001
677 MALAISE 44 0.0001
678 RESPIRATORY DISORDER 3 0.0001
679 DIZZINESS 50 0.0001
680 BURNING SENSATION 7 0.0001
681 PRODUCT PHYSICAL ISSUE 2 0.0001
682 CORONARY ARTERY DISEASE 3 0.0001
683 EXTRA DOSE ADMINISTERED 4 0.0001
684 TASTE DISORDER 2 0.0001
685 OEDEMA PERIPHERAL 12 0.0001
686 NEUTROPHIL COUNT INCREASED 1 0.0001
687 INITIAL INSOMNIA 1 0.0001
688 LIMB DISCOMFORT 3 0.0001
689 POOR VENOUS ACCESS 1 0.0001
690 TOOTH LOSS 2 0.0001
691 FALL 32 0.0001
692 RESPIRATORY FAILURE 7 0.0001
693 PETECHIAE 1 0.0001
694 MUSCULOSKELETAL PAIN 5 0.0001
695 MOUTH ULCERATION 2 0.0001
696 HEAD INJURY 3 0.0001
697 INCONTINENCE 1 0.0001
698 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
699 DRUG INEFFECTIVE 124 0.0001
700 RETCHING 2 0.0001
701 JOINT INJURY 2 0.0001
702 EPISTAXIS 7 0.0001
703 HEREDITARY ANGIOEDEMA 1 0.0001
704 RECTAL HAEMORRHAGE 4 0.0001
705 ASTHENIA 35 0.0001
706 POOR QUALITY SLEEP 2 0.0001
707 DRUG EFFECT DECREASED 5 0.0001
708 ABDOMINAL PAIN UPPER 19 0.0001
709 RASH PRURITIC 5 0.0001
710 FAECES DISCOLOURED 2 0.0001
711 NASOPHARYNGITIS 17 0.0001
712 CONDITION AGGRAVATED 28 0.0001
713 DIABETES MELLITUS 7 0.0001
714 PRODUCT PRESCRIBING ISSUE 2 0.0001
715 CONSTIPATION 20 0.0001
716 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
717 TREATMENT NONCOMPLIANCE 5 0.0001
718 ANXIETY 26 0.0001
719 ASPIRATION 1 0.0001
720 BLOOD GLUCOSE FLUCTUATION 1 0.0001
721 STAPHYLOCOCCAL INFECTION 3 0.0001
722 DEVICE DIFFICULT TO USE 6 0.0001
723 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
724 DENTAL CARIES 1 0.0001
725 RENAL FAILURE 12 0.0001
726 NERVE INJURY 1 0.0001
727 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
728 HYPOTENSION 18 0.0001
729 GLOSSODYNIA 2 0.0001
730 SNEEZING 2 0.0001
731 OCULAR DISCOMFORT 1 0.0001
732 EYE PAIN 5 0.0001
733 PAIN IN EXTREMITY 26 0.0001
734 MICTURITION URGENCY 1 0.0001
735 NEPHROLITHIASIS 4 0.0001
736 GASTRIC HAEMORRHAGE 1 0.0001
737 EYE IRRITATION 5 0.0001
738 ARTHRALGIA 36 0.0001
739 PERICARDIAL EFFUSION 2 0.0001
740 HYPERHIDROSIS 11 0.0001
741 SLEEP DISORDER 6 0.0001
742 FATIGUE 66 0.0001
743 LYMPHADENOPATHY 3 0.0001
744 ATAXIA 1 0.0001
745 NEUROPATHY PERIPHERAL 8 0.0001
746 THERAPY INTERRUPTED 6 0.0001
747 ACCIDENT 1 0.0001
748 RASH ERYTHEMATOUS 4 0.0001
749 POLYNEUROPATHY 1 0.0001
750 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
751 BLOOD GLUCOSE DECREASED 4 0.0001
752 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
753 CONTUSION 8 0.0001
754 DRUG INTOLERANCE 8 0.0001
755 LOCALISED INFECTION 2 0.0001
756 ILL-DEFINED DISORDER 5 0.0001
757 DISCOMFORT 5 0.0001
758 CARDIOMEGALY 1 0.0001
759 GENERALISED OEDEMA 1 0.0001
760 DYSGEUSIA 6 0.0001
761 PHARYNGITIS 1 0.0001
762 CYST 1 0.0001
763 HAIR COLOUR CHANGES 1 0.0001
764 INJECTION SITE DISCOLOURATION 1 0.0001
765 DYSARTHRIA 3 0.0001
766 CELLULITIS 4 0.0001
767 MUSCULAR WEAKNESS 9 0.0001
768 PRODUCT COMPLAINT 2 0.0001
769 MUSCLE ATROPHY 1 0.0001
770 INJECTION SITE IRRITATION 1 0.0001
771 HEADACHE 49 0.0001
772 ABDOMINAL DISCOMFORT 13 0.0001
773 MUCOSAL INFLAMMATION 2 0.0001
774 BEDRIDDEN 1 0.0001
775 DEPRESSED MOOD 4 0.0001
776 EAR INFECTION 2 0.0001
777 EYE HAEMORRHAGE 1 0.0001
778 PROSTATE CANCER 6 0.0001
779 FEAR 2 0.0001
780 FREQUENT BOWEL MOVEMENTS 2 0.0001
781 BLOOD BILIRUBIN INCREASED 2 0.0001
782 THROAT TIGHTNESS 2 0.0001
783 PAIN 45 0.0001
784 SKIN LESION 2 0.0001
785 FEELING COLD 2 0.0001
786 HYPOMAGNESAEMIA 1 0.0001
787 SEPSIS 8 0.0001
788 COORDINATION ABNORMAL 1 0.0001
789 URTICARIA 12 0.0001
790 WOUND 2 0.0001
791 BLINDNESS UNILATERAL 1 0.0001
792 OSTEOARTHRITIS 3 0.0001
793 DEPRESSION 16 0.0001
794 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
795 ACCIDENTAL UNDERDOSE 1 0.0001
796 PARAESTHESIA ORAL 1 0.0001
797 DEVICE LEAKAGE 3 0.0001
798 MENTAL DISORDER 3 0.0001
799 LIVER FUNCTION TEST ABNORMAL 2 0.0001
800 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
801 LIVER DISORDER 3 0.0001
802 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
803 ADVERSE DRUG REACTION 6 0.0001
804 IRRITABILITY 4 0.0001
805 ECONOMIC PROBLEM 1 0.0001
806 THERAPEUTIC RESPONSE DECREASED 4 0.0001
807 OSTEOPENIA 1 0.0001
808 VERTIGO 4 0.0001
809 TINNITUS 3 0.0001
810 FEELING HOT 4 0.0001
811 ADVERSE EVENT 6 0.0001
812 PHARYNGEAL OEDEMA 1 0.0001
813 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
814 EMOTIONAL DISORDER 2 0.0001
815 EJECTION FRACTION DECREASED 1 0.0001
816 BONE DENSITY DECREASED 2 0.0001
817 BRAIN FOG 1 0.0001
818 BLOOD GLUCOSE INCREASED 12 0.0001
819 CYANOSIS 1 0.0001
820 ARRHYTHMIA 3 0.0001
821 CYSTITIS 2 0.0001
822 OBESITY 1 0.0001
823 HYPOTHYROIDISM 2 0.0001
824 METABOLIC ACIDOSIS 2 0.0001
825 NIGHT SWEATS 2 0.0001
826 MUSCLE TIGHTNESS 1 0.0001
827 RHEUMATOID ARTHRITIS 7 0.0001
828 CARDIAC ARREST 5 0.0001
829 BLOOD PRESSURE DECREASED 4 0.0001
830 COAGULOPATHY 1 0.0001
831 LEUKOPENIA 3 0.0001
832 SKIN DISORDER 2 0.0001
833 DRY SKIN 8 0.0001
834 PRURITUS 23 0.0001
835 FACE OEDEMA 1 0.0001
836 INFLAMMATION 3 0.0001
837 PARANOIA 1 0.0001
838 NIGHTMARE 2 0.0001
839 DEVICE USE ERROR 2 0.0001
840 NEOPLASM PROGRESSION 2 0.0001
841 DIARRHOEA 37 0.0001
842 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
843 COLD SWEAT 1 0.0001
844 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
845 HEAD DISCOMFORT 1 0.0001
846 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
847 MOBILITY DECREASED 4 0.0001
848 DRUG EFFECT INCOMPLETE 2 0.0001
849 CRYING 2 0.0001
850 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
851 RESTLESSNESS 2 0.0001
852 HAEMATOCHEZIA 3 0.0001
853 MEDICATION ERROR 3 0.0001
854 AGRANULOCYTOSIS 1 0.0001
855 HEPATIC FUNCTION ABNORMAL 2 0.0001
856 HYPONATRAEMIA 3 0.0001
857 HEPATIC CIRRHOSIS 1 0.0001
858 INTESTINAL OBSTRUCTION 2 0.0001
859 FRACTURE 1 0.0001
860 COLITIS 2 0.0001
861 INCREASED APPETITE 1 0.0001
862 HERPES ZOSTER 3 0.0001
863 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
864 HERNIA 1 0.0001
865 ABDOMINAL PAIN 12 0.0001
866 DYSTONIA 1 0.0001
867 HAEMATOCRIT DECREASED 1 0.0001
868 SYNCOPE 5 0.0000
869 FULL BLOOD COUNT DECREASED 1 0.0000
870 PRODUCT ADMINISTRATION ERROR 1 0.0000
871 NAUSEA 39 0.0000
872 DEVICE BREAKAGE 2 0.0000
873 DYSKINESIA 2 0.0000
874 INJURY ASSOCIATED WITH DEVICE 1 0.0000
875 ERYTHEMA 10 0.0000
876 WITHDRAWAL SYNDROME 2 0.0000
877 HALLUCINATION, VISUAL 1 0.0000
878 MYALGIA 8 0.0000
879 LOSS OF CONSCIOUSNESS 6 0.0000
880 IMPAIRED WORK ABILITY 1 0.0000
881 HYPOAESTHESIA 7 0.0000
882 IRRITABLE BOWEL SYNDROME 1 0.0000
883 ANGIOEDEMA 2 0.0000
884 DEHYDRATION 6 0.0000
885 COLITIS ULCERATIVE 2 0.0000
886 GASTROINTESTINAL DISORDER 4 0.0000
887 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
888 PARAESTHESIA 7 0.0000
889 HEPATIC ENZYME INCREASED 3 0.0000
890 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
891 SEIZURE 5 0.0000
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
893 DISEASE PROGRESSION 5 0.0000
894 COMA 2 0.0000
895 MIGRAINE 4 0.0000
896 SKIN BURNING SENSATION 3 0.0000
897 BLOOD PRESSURE FLUCTUATION 1 0.0000
898 INFECTION 6 0.0000
899 PRESYNCOPE 1 0.0000
900 CEREBRAL INFARCTION 1 0.0000
901 HALLUCINATION 3 0.0000
902 SOMNOLENCE 8 0.0000
903 UNEVALUABLE EVENT 3 0.0000
904 HAEMATEMESIS 1 0.0000
905 CARDIOVASCULAR DISORDER 1 0.0000
906 FLUSHING 4 0.0000
907 HOSPITALISATION 6 0.0000
908 ERECTILE DYSFUNCTION 1 0.0000
909 NO ADVERSE EVENT 7 0.0000
910 HAEMATOMA 1 0.0000
911 EXPOSURE VIA SKIN CONTACT 1 0.0000
912 VOMITING 18 0.0000
913 DEAFNESS 1 0.0000
914 JOINT STIFFNESS 1 0.0000
915 PAIN OF SKIN 1 0.0000
916 PNEUMONITIS 1 0.0000
917 ANAEMIA 7 0.0000
918 INFLUENZA LIKE ILLNESS 3 0.0000
919 MENTAL STATUS CHANGES 1 0.0000
920 RENAL IMPAIRMENT 3 0.0000
921 PANCREATIC CARCINOMA 1 0.0000
922 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
923 MUSCULOSKELETAL STIFFNESS 3 0.0000
924 BONE PAIN 2 0.0000
925 ACUTE MYOCARDIAL INFARCTION 1 0.0000
926 LABORATORY TEST ABNORMAL 1 0.0000
927 HEPATIC FAILURE 1 0.0000
928 EMOTIONAL DISTRESS 4 0.0000
929 SUICIDE ATTEMPT 2 0.0000
930 EPILEPSY 1 0.0000
931 ACUTE KIDNEY INJURY 5 0.0000
932 FEMUR FRACTURE 1 0.0000
933 NERVOUS SYSTEM DISORDER 1 0.0000
934 DRUG-INDUCED LIVER INJURY 1 0.0000
935 PULMONARY EMBOLISM 3 0.0000
936 MOOD SWINGS 1 0.0000
937 MOVEMENT DISORDER 1 0.0000
938 DYSPEPSIA 3 0.0000
939 IMPAIRED HEALING 1 0.0000
940 OSTEONECROSIS 1 0.0000
941 INJECTION SITE PRURITUS 2 0.0000
942 HAEMOGLOBIN DECREASED 3 0.0000
943 HAEMATURIA 1 0.0000
944 HAEMORRHAGE 3 0.0000
945 INJURY 2 0.0000
946 CEREBRAL HAEMORRHAGE 1 0.0000
947 C-REACTIVE PROTEIN INCREASED 1 0.0000
948 AGITATION 2 0.0000
949 INJECTION SITE MASS 1 0.0000
950 THROMBOCYTOPENIA 3 0.0000
951 HOT FLUSH 2 0.0000
952 ABNORMAL BEHAVIOUR 1 0.0000
953 INJECTION SITE HAEMORRHAGE 2 0.0000
954 DRUG DEPENDENCE 4 0.0000
955 THROMBOSIS 2 0.0000
956 TREATMENT FAILURE 2 0.0000
957 CARDIO-RESPIRATORY ARREST 1 0.0000
958 BALANCE DISORDER 2 0.0000
959 PYREXIA 8 0.0000
960 INJECTION SITE PAIN 7 0.0000
961 SUICIDAL IDEATION 2 0.0000
962 HYPOKALAEMIA 1 0.0000
963 COGNITIVE DISORDER 1 0.0000
964 MULTIPLE SCLEROSIS 1 0.0000
965 INTERSTITIAL LUNG DISEASE 1 0.0000
966 HYPOGLYCAEMIA 1 0.0000
967 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
968 ECZEMA 1 0.0000
969 DERMATITIS ATOPIC 1 0.0000
970 DISTURBANCE IN ATTENTION 1 0.0000
971 OVERDOSE 4 0.0000
972 DEPENDENCE 1 0.0000
973 ARTHROPATHY 1 0.0000
974 BLISTER 1 0.0000
975 LETHARGY 1 0.0000
976 CHILLS 2 0.0000
977 BLADDER CANCER 1 0.0000
978 EXPOSURE DURING PREGNANCY 1 0.0000
979 DEEP VEIN THROMBOSIS 1 0.0000
980 BLOOD CREATININE INCREASED 1 0.0000
981 PSORIASIS 2 0.0000
982 INFUSION RELATED REACTION 1 0.0000
983 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
984 INJECTION SITE REACTION 1 0.0000
985 ACNE 1 0.0000
986 INJECTION SITE SWELLING 1 0.0000
987 DRUG INTERACTION 2 0.0000
988 INJECTION SITE BRUISING 1 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
990 PLATELET COUNT DECREASED 1 0.0000
991 INJECTION SITE ERYTHEMA 1 0.0000